765 Results

People

  1. Cordon-Cardo
    Cordon-Cardo
  2. Scher
    Scher
  3. Bertino
    Bertino
  4. Old
    Old
  5. Cheung
    Cheung
  6. Livingston
    Livingston
  7. Rosen
    Rosen
  8. Tong
    Tong
  9. Kris
    Kris
  10. Fair
    Fair

Groups

  1. Department of Medicine (318)
  2. Solid Tumor Oncology Division (248)
  3. GSK Faculty (228)
  4. Sloan Kettering Institute Faculty (183)
  5. Surgery (129)
  6. Molecular Pharmacology and Chemistry Program Faculty (116)
  7. Tow Center for Developmental Oncology (TCDO) (104)
  8. Genitourinary Oncology Service (98)
  9. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (93)
  10. Epidemiology and Biostatistics (91)
  1. "article"
  2. "American Association for Cancer Research"
Formats
  1. Journal Article (754)
  2. Editorial (7)
  3. Review (4)
Groups
  1. Department of Medicine (318)
  2. Solid Tumor Oncology Division (248)
  3. GSK Faculty (228)
  4. Sloan Kettering Institute Faculty (183)
  5. Surgery (129)
  6. Molecular Pharmacology and Chemistry Program Faculty (116)

More Groups

People
  1. Carlos Cordon-Cardo (64)
  2. Howard Scher (41)
  3. Marc Ladanyi (31)
  4. Joseph Bertino (27)
  5. Lloyd Old (24)
  6. Nai-Kong Cheung (23)

More People

Years
  1. 2024 (11)
  2. 2023 (9)
  3. 2022 (17)
  4. 2021 (15)
  5. 2020 (15)
  6. 2019 (23)

More Years

Publications
  1. Cancer Research (353)
  2. Clinical Cancer Research (264)
  3. Cancer Epidemiology Biomarkers and Prevention (58)
  4. Cancer Discovery (36)
  5. Cell Growth & Differentiation (22)
  6. Molecular Cancer Therapeutics (18)

More Publications

Publishers
  1. American Association for Cancer Research (765)

Results (765)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • FcgRIIB is an immune checkpoint limiting the activity of Treg-targeting antibodies in the tumor microenvironment
    Journal Article

    Knorr, D. A.; Blanchard, L.; Leidner, R. S.; Jensen, S. M.; Meng, R.; Jones, A.; Ballesteros-Merino, C.; Bell, R. B.; Baez, M.; Marino, A.; more...
    Cancer Immunology Research (2024)

    Fulltext@MSK | Save
  • Marital status, living arrangement, and survival among individuals with advanced prostate cancer in the international registry for men with advanced prostate cancer
    Journal Article

    Chen, N.; McGrath, C. B.; Ericsson, C. I.; Vaselkiv, J. B.; Rencsok, E. M.; Stopsack, K. H.; Guard, H. E.; Autio, K. A.; Rathkopf, D. E.; Enting, D.; more...
    Cancer Epidemiology Biomarkers and Prevention (2024)

    Fulltext@MSK | Save
  • Passenger gene coamplifications create collateral therapeutic vulnerabilities in cancer
    Journal Article

    Bei, Y.; Bramé, L.; Kirchner, M.; Fritsche-Guenther, R.; Kunz, S.; Bhattacharya, A.; Rusu, M. C.; Gürgen, D.; Dubios, F. P. B.; Köppke, J. K. C.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Evaluation of algorithms using automated health plan data to identify breast cancer recurrences
    Journal Article

    Aiello Bowles, E. J.; Kroenke, C. H.; Chubak, J.; Bhimani, J.; O'Connell, K.; Brandzel, S.; Valice, E.; Doud, R.; Theis, M. K.; Roh, J. M.; more...
    Cancer Epidemiology Biomarkers and Prevention (2024)

    Fulltext@MSK | Save
  • Integrative analyses of tumor and peripheral biomarkers in the treatment of advanced renal cell carcinoma
    Journal Article

    Choueiri, T. K.; Donahue, A. C.; Braun, D. A.; Rini, B. I.; Powles, T.; Haanen, J. B. A. G.; Larkin, J.; Mu, X. J.; Pu, J.; Teresi, R. E.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Therapy-induced senescence contributes to the efficacy of abemaciclib in patients with dedifferentiated liposarcoma
    Journal Article

    Gleason, C. E.; Dickson, M. A.; Klein, M. E.; Antonescu, C. R.; Gularte-Mérida, R.; Benitez, M.; Delgado, J. I.; Kataru, R. P.; Tan, M. W. Y.; Bradic, M.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Impact of rare structural variant events in newly diagnosed multiple myeloma
    Journal Article

    Chojnacka, M.; Diamond, B.; Ziccheddu, B.; Rustad, E.; Maclachlan, K.; Papadimitriou, M.; Boyle, E. M.; Blaney, P.; Usmani, S.; Morgan, G.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • ESR1 F404 mutations and acquired resistance to fulvestrant in ESR1-mutant breast cancer
    Journal Article

    Kingston, B.; Pearson, A.; Herrera-Abreu, M. T.; Sim, L. X.; Cutts, R. J.; Shah, H.; Moretti, L.; Kilburn, L. S.; Johnson, H.; Macpherson, I. R.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Micronuclei and cancer
    Review

    Di Bona, M.; Bakhoum, S. F.
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • SAR-096: Phase II clinical trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL) and leiomyosarcoma (LMS)
    Journal Article

    Movva, S.; Matloob, S.; Handorf, E. A.; Choy, E.; Merriam, P.; Flieder, D. B.; Cai, K. Q.; Zhou, Y.; Tetzlaff, E. D.; Pagan, C.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save